This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: 9541659 Canada Inc.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Aleksey V Pichugin: Innovator in Pharmaceutical Compositions
Introduction
Aleksey V Pichugin is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions with antibacterial and antiviral properties. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Pichugin's latest patents focus on pharmaceutical compositions that exhibit antibacterial, antiviral, and immunostimulatory activities. The first patent details a composition that includes an active substance capable of treating bacterial or viral infections while enhancing immune function. The second patent outlines a method for producing a substance with similar antimicrobial and immunostimulatory activities, specifically targeting dendritic cells. This method utilizes chopped potato sprouts as raw materials, which undergo a series of extraction and purification processes to yield a peptidoglycan with a molecular weight ranging from 500 kD to 17,000 kD.
Career Highlights
Aleksey V Pichugin is associated with 9541659 Canada Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing medical science through the development of effective treatments.
Collaborations
Pichugin collaborates with notable colleagues, including Ravshan Ataullakhanov and Tatyana M Melnikova, who contribute to his research and development efforts.
Conclusion
Aleksey V Pichugin stands out as an influential inventor in the pharmaceutical industry, with a focus on creating compositions that enhance immune responses and combat infections. His innovative work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile